Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial

By sjmartinez • February 21, 2024

Schou M, Claggett B, Miao ZM, Fernandez A, Filippatos G, Granger C, Jering K, Maggioni AP, McCausland F, Villota JN, Rouleau JL, Mody FV, van der Meer P, Vinereanu D, McGrath M, Zhou Y, Mann DL, Solomon SD, Steg PG, Braunwald E, McMurray JJV, Pfeffer MA, Køber L. Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial. Eur J Heart Fail. 2024 Jan;26(1):130-139. doi: 10.1002/ejhf.3079. Epub 2023 Nov 29. PMID: 37933184.

Tags: ACE inhibitors, Cardiology/Epi, drug adherence, heart failure, left ventricular dysfunction, mineralocorticoid receptor antagonists, Myorcardial infarction, Publications, sacubitril/valsartan, Veterans Administration

Racial and Ethnic Disparities in Referral to Outpatient Heart Failure Management at Hospital Discharge: A Get With The Guidelines Analysis

Wang M, He X, Crawford K, Ko YA, Dickert NW, Patel SA, Pandey A, DeFilippis EM, Breathett K, Cogswell R, Yancy CW, Fonarow GC, Morris[...]

Biophysical modelling of intrinsic cardiac nervous system neuronal electrophysiology based on single-cell transcriptomics

Gupta S, Gee MM, Newton AJH, Kuttippurathu L, Moss A, Tompkins JD, Schwaber JS, Vadigepalli R, Lytton WW. Biophysical modelling of intrinsic cardiac nervous system[...]

Short-Term Safety and Effectiveness for Tenecteplase and Alteplase in Acute Ischemic Stroke

Rousseau JF, Weber JM, Alhanti B, Saver JL, Messé SR, Schwamm LH, Fonarow GC, Sheth KN, Smith EE, Mullen MT, Silva GS, Mac Grory B,[...]